Remo Panaccione
0000-0002-5247-940X
University of Calgary
7 papers found
Refreshing results…
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Long-term safety of vedolizumab for inflammatory bowel disease
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Reduction in surgical stoma rates in Crohn's disease: a population‐based time trend analysis
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease
Ulcerative Colitis: Shifting Sands
Missing publications? Search for publications with a matching author name.